Stephanie Heidemann, MD
Clinical Assistant Professor of Pediatrics (Oncology)
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Oncology
3401 Civic Center Blvd
Philadelphia, PA 19104
Division of Oncology
3401 Civic Center Blvd
Philadelphia, PA 19104
Education:
MD
Westfälische Wilhelms-Universität, Münster, Germany, 2005.
Permanent linkMD
Westfälische Wilhelms-Universität, Münster, Germany, 2005.
Selected Publications
Caitlin W. Elgarten, Stephanie Heidemann, Jason L. Freedman, Stephan A. Grupp, Patricia Hankins, Stephan Kadauke, Yimei Li, Barbara McGlynn, Timothy S. Olson, Yongping Wang, Lisa Wray MD, Lei Wang, Alix E. Seif, Nancy J. Bunin: Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies. Transplantation and Cellular Therapy 30(2): S9-S10, February 2024.Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, Bunin NJ: Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy. Biol Blood Marrow Transplant. Biol Blood Marrow Transplant Mar 2020.
Stephanie Heidemann, MD, Brian Bursic, Sasan Zandi, Hongbing Li, Sagi Abelson, Robert J. Klaassen, Sharon Abish, Meera Rayar, Vicky R. Breakey, Houtan Moshiri, Santhosh Dhanraj, Richard de Borja, Adam Shlien, John E. Dick, and Yigal Dror: Cellular and Molecular Architecture of Hematopoietic Stem Cell and Progenitors in Genetic Models of Inherited Bone Marrow Failure. JCI Insight 5(4): e13108, Feb 2020.
LeGrand JN, Heidemann SC, Swindle CS, and Klug CA.: Identification of Cytogenetically Normal Human CD34+CD38+ Hematopoietic Stem/Progenitor Cells from Inv(16)+ Leukemic Bone Marrow. Blood 124(21): 1059, Dec 2014.
Heidemann SC, Chavez V, Landers CJ, Kucharzik T, Prehn JL, Targan SR : TL1A selectively enhances IL-12/IL-18-induced NK Cell Cytotoxicity against NK-Resistant Tumor Targets J Clin Immunol 30(4): 531-8, Jul 2010.